BUT it went south todayImugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company’s HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor; and CF-33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. Imugene Limited was incorporated in 1986 and is headquartered in Sydney, Australia.
Has jumped out of the box!!!" I'm hearing on the news all this activity about cures and treatments for cancer a" breakthrough". IMU may be the next big thing!.
BUT it went south today
I may of jumped the gun on 'imu' . For now. I"m still not sure if its the trade I'm thinking off. I see it breaking even and look forward to watch it this week. I need more research...
Picked up to close flat in the end but has been a stellar rise lately.BUT it went south today
https://www.imugene.com/Up 0.025 nearly 10% . SFA I know but tells me where its going! half day! climbing!
Has jumped out of the box!!!" I'm hearing on the news all this activity about cures and treatments for cancer a" breakthrough". IMU may be the next big thing!.
Next Big thing like BTC or CSL
I wouldn't say as big as csl, but it certainly jumped out of the gate, On top of that announcement...Next Big thing like BTC or CSL
A lot of potential here; https://www.imugene.com/Picked up to close flat in the end but has been a stellar rise lately.
They have about $30 mill in the coffers, but are already a $1.25 Billion dollar Company.
The Bio-Tech space is a tough one at the best of times (IBX is a good current example)
If they do succeed with their technology/s, I guess the big question is
How much higher can the SP go in the short/medium term?
I assume long term holders will be happy to sit and wait if they believe in the Companies potential.
A bit of chart poetry to display the current shorter term situation (in my opinion)
Thanks mate. Your optimism and supporting facts are working for my little cash box for sure. Take careI wouldn't say as big as csl, but it certainly jumped out of the gate, On top of that announcement...
SYDNEY, Australia, 21 April 2021:Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, today announced a clinical milestone has been achieved for its HER-Vaxx cancerimmunotherapy in the Phase 2 gastric cancer clinical trial. Following completion of recruitment in January 2021, the important clinical endpoint of Progression Free Survival (PFS) has been met after the statistically significant required number of PFS events has occurred. Data from these 24 events will now be analysed with the final PFS read-out expected within months.
I look forward to watching it's progress climb in those next couple of months, and onward, with the progression of its achievements.
I'd like to refer back to Barneys post earlier;
A lot of potential here; https://www.imugene.com/
Rome was not built in a day!So, the question is;
Are the directors going to dump into the higher prices now.
I note Leslie Chong / (Imugene) was on ABC's The Business last night.
One might expect another pump up today....
Not held.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?